title: Comment on Mita et al. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial. Diabetes Care 2016;39:455-464.
authors.affiliation: Division of Endocrinology and Metabolic Diseases, Department of Medical, Surgical, Neurological, Metabolic Sciences and Aging, Second University of Naples, Naples, Italy mariaida.maiorino@unina2.it.
authors.forename: Maria Ida
authors.initials: MI
authors.lastname: Maiorino
authors.affiliation: Division of Endocrinology and Metabolic Diseases, Department of Medical, Surgical, Neurological, Metabolic Sciences and Aging, Second University of Naples, Naples, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Bellastella
authors.affiliation: Division of Endocrinology and Metabolic Diseases, Department of Medical, Surgical, Neurological, Metabolic Sciences and Aging, Second University of Naples, Naples, Italy.
authors.forename: Dario
authors.initials: D
authors.lastname: Giugliano
authors.affiliation: Diabetes Unit, Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy.
authors.forename: Katherine
authors.initials: K
authors.lastname: Esposito
mesh_terms: D059168:Carotid Intima-Media Thickness; D003924:Diabetes Mellitus, Type 2; D018450:Disease Progression; D006801:Humans; D007328:Insulin; D000068900:Sitagliptin Phosphate
chemical_list: D007328:Insulin; D000068900:Sitagliptin Phosphate